15 min listen
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
ratings:
Length:
63 minutes
Released:
Mar 6, 2024
Format:
Podcast episode
Description
Dr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here (https://www.researchtopractice.com/YiR2023/Gastroesophageal).
CME information and select publications here (https://www.researchtopractice.com/YiR2023/Gastroesophageal).
Released:
Mar 6, 2024
Format:
Podcast episode
Titles in the series (100)
Dr Michael Pishvaian Comments on the Use of PARP Inhibition in the Management of Pancreatic Cancer: Is it worthwhile to treat pancreatic cancer? Dr Michael Pishvaian from Johns Hopkins University discusses the use of the PARP inhibitor olaparib and other new developments in the disease. by Oncology Today with Dr Neil Love